Objectives-To determine (a) the influence of HIV in developing osteoarticular infections in intravenous drug abusers (IVDAs) and (b) the differences between the clinical features of osteoarticular infections in IVDAs and a control group of non-IVDAs. Methods-A comparative study of the clinical features of osteoarticular infections in all HIV positive and HIV negative IVDAs admitted to the departments of rheumatology and internal medicine during a 10 year period was carried out.
The joint infections of all IVDAs, irrespective of HIV status, were compared with those of a control group of nonIVDAs lacking risk factors for HIV infection. Results-A total of482 HIV positive and 85 HIV negative IVDAs was studied, in whom 25 (5%) and six (7%) osteoarticular infections were found respectively. There were no differences in age, sex, joints affected, and causative agents between these two groups. A comparison of the 31 ( 
5/5%) osteoarticular infections in all
IVDAs with 21 infections in 616 (3.4%) non-IVDAs showed significant differences in the mean age (27.5 v 54) , the frequency of affection of the axial joints (hip, sacroiliac, and sternocostal joints) (64.5% v 16.6%), and in the incidence of Candida albicans (19% v 0%). Conclusions-(1) HIV may not predispose to osteoarticular infections in IVDAs. (2) The hip, sacroiliac, and sternocostal joints (axial joints) were most commonly affected in IVDAs. (3) In Spain, unlike other countries, Gram positive bacteria and C albicans seem to be predominant agents in osteoarticular infections in IVDAs, with a low incidence of Gram negative bacteria.
(Ann Rheum Dis 1993; 52: 570-574)
The human immunodeficiency virus (HIV), one of the main protagonists of the last decade, has a role in all clinical fields. In 1985 psoriasis was first reported in relation to HIV,1 and in 1987 Reiter's syndrome was described as a possible HIV associated disease.2 Since these initial reports some investigators have studied the incidence and prevalence of rheumatic syndromes in association with HIV infection. A predominance of seronegative spondylarthritis in studies among homosexual men35 and of osteoarticular infections among intravenous drug abusers (IVDAs)6-10 may exist.
Furthermore, septic arthritis has been found only rarely when homosexuality is the principal risk factor for HIV infection.3 This suggests that risk factors for HIV infection may influence the expression of HIV related rheumatic syndromes.
On the other hand, septic arthritis in IVDAs might have different features than in nonIVDAs. The former might have infections of the axial joints more commonly than the latter; this has not been proved.
The objectives of our study were to determine (a) the influence of HIV on the incidence of osteoarticular infections in IVDAs and (b) the differences between osteoarticular infections in IVDAs and non-IVDAs.
Patients and methods
We included in the study all IVDAs (with or without HIV infection) admitted to the department of internal medicine and rheumatology of our negative patients (range 23-37 years). In the HIV positive group 80% were men and 20% women, and the HIV negative group comprised 83% men and 17% women. We found 25 osteoarticular infections (5%) in HIV positive patients and six (7%) in HIV negative patients. In the first group the affected joints were the hip (seven patients (28%)), sacroiliac joint (four (16%)), stemocostal joint (four (16%)), knee (three (12%)), and shoulder and disc L3-4 in one case each. In one patient a polyarticular involvement of elbows and wrists was found, and in another the ankle and shoulder were both affected. Osteomyelitis was present in three patients (wrist, femoral neck, and tibia). In HIV negative patients the affected joints were the sacroiliac joint in three (50%) patients and hip, sternocostal joint, and knee in one each. Although sacroiliac joint infection was more common in HIV negative than in HIV positive patients (50% v 16%), the difference was not significant. Although osteomyelitis was not found in the HIV negative group, statistical analysis was not possible owing to the small number of HIV positive patients with osteomyelitis.
In the 25 HIV positive patients with osteoarticular infections the causative agents were Staphylococcus aureus in 12 (48%), Candida albicans in five (20%), and Mucor, Neisseria gonorrhoeae, Mycobacterium tuberculosis, Staphylococcus epidermidis, Streptococcus viridans, Streptococcus equisimilis, and Streptococcus sanguis in one case each. Additionally, S aureus and Bacteroides melaninogenicus were found in one patient.
In the six HIV negative patients with osteoarticular infections the causative agents were S aureus in four (67%) and C albicans and M tuberculosis in one case each. No significant differences in the incidence of infections, age, sex, joints affected, and causative agents were found between HIV positive and negative patients (table 2) .
Of the 25 HIV positive patients with osteoarticular infections, 11 (44%) were in CDC group II, four (16%) in group III, four (1/6%) in group IV-C2, and six (24%) in group IV-Cl and had criteria of AIDS. In 16 of the 21 non-IVDAs with osteoarticular infections a predisposing factor was found. Six had previous skin or wound infections, and rheumatoid arthritis, diabetes mellitus, pneumonia, and alcoholism were each present in two patients, one had systemic lupus erythematosus, and another had multiple myeloma. In addition to the soft tissue and skin infections commonly found in IVDAs, six of the 31 with osteoarticular infections (20%) had disseminated candidiasis (with the sternocostal joint affected in five patients and the hip in one) and six (20%) had infectious endocarditis. Of these, five had tricuspid endocarditis caused by S aureus and one had mitral endocarditis due to S sanguis. (This patient also had osteomyelitis of the tibia.)
The affected joints in the 21 non-IVDAs were knees (eight patients (38%)), intervertebral discs (three (144%)), wrists (two (10%)), elbows (two (10%), hips (two (10%)), and ankle, sacroiliac joint, and shoulder in one case each. Another patient had septic oligoarthritis of the wrist, shoulder, and ankle. Classifying the affected joints as axial (sternocostal, sacroiliac, intervertebral, and hip joints) or peripheral, we found that the axial joints were more commonly affected in the IVDAs than in the non-IVDAs (64-5% v 16&6%; p=000034). The knee was most commonly affected in nonIVDAs (eight v four cases), but this difference was not significant when compared with the IVDAs.
The bacteria responsible for the osteoarticular infections in the non-IVDAs were S aureus (67%)), M tuberculosis (four (19%)), S pneumoniae (two (10%)), and B fragilis in one case (5%). The only significant difference found between IVDAs and non-IVDAs was the prevalence of C albicans (five v 0; p=003). Although there are some differences between osteoarticular infections in IVDAs and nonIVDAs, we found no studies in which these differences were specifically examined. Our paper confirms that in IVDAs a significantly greater number of infections of axial jointsnamely, hip, sacroiliac, and sternocostal joints-are present than in non-IVDAs. In addition, C albicans is found significantly more often in IVDAs than in non-IVDAs.
Discussion
All the non-IVDAs studied were hospital inpatients and, furthermore, almost all (76%) had a predisposing factor for joint infection. Thus the incidence of osteoarticular infections Several factors may account for the high incidence of infections in IVDAs: (a) HIV infection might be an important factor, but our data suggest that in osteoarticular infections this virus plays little part; (b) S aureus, the most common cause of infection, has not been found in heroin samples, but IVDAs are often carriers of S aureus36; (c) unsterile drugs are injected with dirty needles and syringes; (d) dental hygiene is often poor; (e) bacterial clearance by the tracheobronchial system can be decreased during intoxication; (t) promiscuity and prostitution increase the risk of transmitting infective agents; and, finally, (g) cell mediated immunity may be impaired in IVDAs not only by HIV infection but also by intravenous drugs themselves. 37 It is known that infectious agents each reach the synovial space through the bloodsteam.3' Why do IVDAs have a greater number of infections in the axial joints? Perhaps, the site of injection may play a part.27 This hypothesis, however, does not completely explain the increase of infections of sacroiliac, hip, and other axial joints in IVDAs. The high incidence of sternocostal infections is explained by disseminated candidiasis, which was present in 20% of our IVDAs. We found five cases of sternocostal infection and all were caused by this agent. The high incidence of C albicans in IVDAs seems to be due to the use of brown heroin mixed with contaminated lemon.38 39 Therefore, the presence of disseminated candidiasis does not imply immune suppression related to AIDS. Systemic candidiasis has an initial phase with a septicaemic febrile syndrome that lasts between one and three days and a second phase characterised by the appearance of metastatic lesions, such as cutaneous (folliculitis, nodules, etc), ocular, and articular disease. The time between the acute phase and the articular disease ranges from 15 days to five months,38 and stemocostal infection is the most common and characteristic joint disease.39 The reason for this is unknown.
In conclusion, after searching for the influence of HIV infection in developing osteoarticular infections in IVDAs, we found that HIV seems to play little part. Intravenous drug abusers are younger and have a greater number of axial joint infections and have more arthritis due to candida than non-IVDAs. The epidemiology of the infections in our patients, similar to that reported by others in Spain, shows less Gram negative bacterial infections and methicillin resistant S aureus than in the United States.
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